Objective: To discuss susceptible factors analysis of multivessel coronary artery diseaseof STEMI、prognostic assessment and whether patients can benefit from re-PCI treatment.Methods: The study databasement was established by retrospecrively adopting patient’smedical record information and follow-up method.We retrospectively collected300cases thatdignosed with Acute ST segment elevation myocaridal infarction paraller PCI treatment inCenter for Cardiovascular Medicine of Jilin University of Bethune First Hospital by usingcall-inquiry and outpatient or hospitallizaiotn follow-ups during Oct.2012to Ocr.2013. Thenumber of patients in all enrolled is214. Follow-up events including readmission,severearrhythmia, MI and death.(Female:96cases/Male:118cases/Average age:60.91±7.75).Result: The blood lipid metabolic abnormalities in multivessel coronary artery disease isof great significance.So the positive control LDL level has become an important measure intreatment of coronary heart disease.The sequential treatments after surgery play a significantrole in changing its prognosis level of patients with multivessel coronary artery disease.ThePCI treatment gives a greater benefit than conservative treatment on the part of MCADpatients who found lumen renarrowing or other excepctions during regular reexaminations.Conclusion: Hypertension and dyslipidema is one of the important risk factor forMCAP.The incidence of adverse events of MCAD is dramatically higher than that ofSCAD,As for patients with MCAD re-PCI treatment can effectively improve the prognosislevels and living standards of patients. |